End-to-End Clinical Trial & GMP Services in Chile
Simplifying GxP Compliance for a Safer, Smarter Future
Chile’s pharmaceutical market is expanding due to increased healthcare demand and government innovation support. The National Medicines Agency (ANAMED) regulates the market, ensuring compliance with ICH-GCP guidelines and GMP standards. A significant advantage is the 2026 introduction of a Regulatory Reliance Framework for GMP compliance verification, leveraging inspection reports from international health authorities. As a PAHO-designated Regional Reference Regulatory Authority, Chile serves as a strategic gateway to Latin America.
Zenovel offers regulatory and scientific solutions to ensure GCP/GMP compliance, expedite market access, and uphold product quality and efficacy in Chile’s life sciences sector.
GCP Services in Chile: Expert Clinical Trial Compliance & Audit Support
Strengthening Clinical Trial Quality Through GCP Excellence
Zenovel provides GCP services in Chile aligned with ANAMED (National Medicines Agency) and ICH E6(R3) guidelines. Our offerings help pharmaceutical and biotech companies achieve full compliance and inspection readiness.
- GCP compliance & audit services – risk‑based quality management, CAPA handling, and TMF review
- Inspection readiness & sponsor oversight – mock audits, documentation control, and site/vendor compliance
With Chile adopting ICH E6(R3) and ANAMED enforcing rigorous standards, Zenovel ensures your clinical trials meet both local and international expectations.
Computer System Validation (CSV) Services in Chile for GxP & GAMP 5 Compliance
Achieve Regulatory Confidence with End-to-End CSV Services in Chile
Zenoval provides CSV services in Chile aligned with ANAMED requirements, GAMP 5 guidelines, and 21 CFR Part 11 standards. Our risk‑based validation ensures GxP systems (EDC, CTMS, LIMS, ERP) meet data integrity and audit trail expectations.
Our CSV services in Chile include:
- IQ/OQ/PQ protocol execution & lifecycle documentation
- System validation for clinical, laboratory & enterprise platforms
- Audit‑ready compliance for ANAMED and international inspections
With Chile’s growing emphasis on computerized system integrity, Zenovel helps you maintain secure, traceable, and inspection‑ready operations.
GCP Audit Services in Chile for Clinical Trial Compliance & Inspection Readiness
We Ensure Every Clinical Trial Meets GCP & Regulatory Expectations
Clinical trials in Chile are overseen by the National Medicines Agency (ANAMED), which adheres to the ICH E6(R3) Good Clinical Practice guidelines and conducts rigorous inspections to ensure compliance. ANAMED accepts inspection reports from recognized authorities such as PAHO/WHO and PIC/S. Zenovel provides GCP audit services to assist sponsors, CROs, and sites in identifying and rectifying compliance issues before ANAMED evaluations.
Our GCP Audit Services in Chile Include:
- Site audits, sponsor audits, vendor audits & system‑level quality reviews
- Alignment with ICH E6(R3) guidelines, ANAMED requirements, and international standards
- Assessment of protocol adherence, informed consent, documentation accuracy & data integrity
- CAPA development, risk‑based quality improvement & inspection readiness planning
Zenovel helps organizations identify compliance gaps to prepare for ANAMED and global inspections. With expertise in clinical quality assurance and GCP compliance in Chile, we mitigate risks, enhance operational discipline, and strengthen sponsor confidence for GCP audits and trial integrity.
CRO Setup and Upgradation Services in Chile for GCP‑Compliant Clinical Research Solutions
Advancing CRO Upgradation Services for Modern Clinical Trial Demands
Zenovel offers expert CRO setup and upgradation services in Chile to help pharmaceutical and biotech companies establish or optimize clinical research operations aligned with ANAMED requirements and ICH E6(R3) guidelines.
- Infrastructure planning, SOP development & QMS implementation
- Risk‑based monitoring (RBM), CAPA systems & inspection readiness
- For existing CROs: process optimization, regulatory compliance & audit preparation
- Scalable, GCP‑compliant frameworks for seamless trial execution
With Chile’s evolving regulatory landscape, Zenovel ensures your CRO is inspection‑ready, efficient, and globally competitive.
PK Statistical Review Services in Chile for Pharmacokinetic Analysis & Regulatory Support
Streamlining Clinical Data Analysis with Advanced PK‑Stat Review Services in Chile
Zenovel’s PK‑Stat review services in Chile provide precise pharmacokinetic analysis aligned with ANAMED requirements, ICH E6(R3), and international standards (FDA, EMA). Our expert interpretation ensures data integrity, minimizes variability, and supports regulatory submissions.
Our PK‑Stat Services in Chile Include:
- Non‑compartmental analysis (NCA) & population PK modeling
- PK/PD evaluation aligned with ANAMED and global expectations
- Clinical biostatistics & data review for accuracy and validation
- CDISC compliance (SDTM/ADaM) & submission‑ready outputs
Our expert team focuses on scientific and regulatory data interpretation, working closely with clinical pharmacology and biostatistics to ensure data integrity, minimize variability, and improve decision-making in trials. We are your trusted partner for PK‑Stat and biostatistics in Chile.
Pre-Inspection Readiness Services in Chile for GCP Compliance & Audit Preparation
Achieve Audit Readiness with Precision, Compliance, and Confidence
Regulatory inspections are essential for clinical systems. Zenovel offers pre-inspection readiness services in Chile, improving GCP compliance prior to audits and complying with ANAMED requirements and ICH E6(R3) guidelines. We aid sponsors, CROs, and sites in identifying and mitigating compliance risks before ANAMED evaluations.
Our Pre‑Inspection Readiness Services in Chile Include:
Comprehensive gap assessments & mock inspections (ANAMED‑style)
Documentation reviews & quality system evaluations
Assessment of informed consent, protocol adherence, data integrity & vendor oversight
CAPA effectiveness review & inspection response strategy
Zenovel improves QMS processes by simulating regulatory scrutiny, aiding clinical and quality teams to achieve successful inspections and smooth regulatory transitions in Chile.
Risk-Based Monitoring (RBM) Services in Chile for Clinical Trial Oversight
We Enhance Trial Quality Through RBM Excellence in Chile
Zenovel’s Risk-Based Monitoring (RBM) services in Chile enhance clinical trial oversight by improving patient safety and data quality. These services comply with ANAMED requirements and ICH E6(R3) guidelines, addressing the shortcomings of traditional monitoring methods.
Our RBM services in Chile include the following:
- Centralized monitoring & key risk indicator (KRI) development
- Site risk assessment & real‑time data review strategies
- Alignment with ANAMED expectations and ICH E6(R3) guidelines
- Transition from routine on‑site to data‑driven, risk‑proportionate monitoring
Our team works with clinical operations and data management teams to create risk-based monitoring plans that enhance issue detection and trial efficiency in multi-site studies in Chile. This method allows for early risk identification, optimal resource utilization, and improved regulatory compliance, positioning Zenovel as a crucial partner for efficient and compliant clinical trials.
Sponsor Oversight Services in Chile for Clinical Trial Governance
We Advance Clinical Research Integrity with Sponsor Oversight Expertise in Chile
Zenovel provides sponsor oversight services in Chile to ensure visibility, control, and accountability for trial sponsors. This is achieved by complying with ANAMED requirements and ICH E6(R3) guidelines, thereby enhancing oversight across various vendors, sites, and CROs.
Our Sponsor Oversight Services in Chile Include:
- CRO performance oversight & vendor management
- Quality monitoring & risk‑based governance frameworks
- KPI tracking, responsibility mapping & consistent execution oversight
- Adherence with ICH E6(R3) guidelines and ANAMED expectations
Zenovel partners with sponsor teams in Chile to enhance quality systems, communication, and risk management in clinical trials, offering expertise in governance, accountability, and inspection readiness for complex operations.
Good Manufacturing Practice (GMP) Services in Chile for Pharma Compliance
We Drive Quality, Safety, and GMP Compliance Across Chile
In Chile, pharmaceutical manufacturing is regulated by the National Medicines Agency (ANAMED), following GMP standards aligned with WHO GMP and PIC/S. As a PAHO/WHO Regional Reference Regulatory Authority (level IV), Chile enforces rigorous GMP requirements for both active substances and finished products. Zenovel offers GMP services to help pharmaceutical and biotech companies achieve compliance and enhance operational reliability.
Our GMP services in Chile include the following:
- GMP audits, quality system (QMS) design & review
- Deviation management, CAPA implementation & documentation control
- Alignment with ANAMED, WHO GMP, PIC/S, and global standards
- Inspection readiness support & risk‑based compliance frameworks
Zenovel collaborates with quality and manufacturing teams to strengthen compliance systems and minimize risks, offering practical strategies for effective regulatory outcomes. We are a reliable GMP partner in Chile, specializing in manufacturing and inspection‑ready operations.
GMP Audit Services in Chile for Manufacturing Quality Assurance
We Ensure Products Meet Rigorous Safety and Efficacy Standards with GMP Audit Services in Chile
Pharmaceutical manufacturing in Chile is regulated by the ANAMED, which enforces strict penalties for quality lapses. Zenovel offers GMP audit services in Chile to ensure adherence to WHO GMP, PIC/S, and international standards through expert evaluations of manufacturing quality assurance.
Our GMP Audit Services in Chile include:
- Production processes & quality management systems (QMS)
- Documentation control, batch records & CAPA effectiveness
- Vendor quality systems & root cause analysis of compliance risks
- Alignment with ANAMED requirements, WHO GMP, and PIC/S standards
Zenovel views audits as opportunities for regulatory intelligence, leveraging skilled pharmaceutical quality assurance experts to enhance manufacturing settings for ANAMED inspections and global evaluations. As a GMP quality assurance partner in Chile, we elevate audit confidence through expert validation.
Plant Set-up & Upgradation in Chile for Maintaining GMP Compliance
Advancing Pharmaceutical Facilities to Global and Regulatory‑Compliant GMP Standards in Chile
Establishing or upgrading a pharmaceutical manufacturing facility in Chile requires compliance with regulations from the ANAMED, ensuring alignment with WHO GMP, PIC/S standards, and international guidelines. Zenovel offers services to create GMP‑compliant, scalable, and inspection‑ready manufacturing environments in Chile.
Our GMP Plant Setup & Upgradation Services in Chile are:
- Plant design review, cleanroom classification & HVAC validation
- Equipment qualification (IQ/OQ/PQ) & QMS integration
- For existing facilities: modernization, gap closure, contamination control & process optimization
- Alignment with ANAMED, WHO GMP, PIC/S, and global standards
Zenovel improves operational efficiency and compliance through engineering and regulatory expertise, focusing on ANAMED inspections. Our team works closely with manufacturing, QA, and validation teams to reduce regulatory risks and streamline processes.
GMP Pre-inspection Readiness Services in Chile For Assuring Compliance
We Assist in GMP Inspection Readiness and Assure Compliance Confidence in Chile
Regulatory inspections are essential, and inadequate preparation can lead to findings, production delays, or license suspensions. Zenovel offers expert GMP pre‑inspection readiness services in Chile, ensuring compliance with ANAMED standards, WHO GMP, and PIC/S expectations.
Gap analysis of quality systems, production processes & documentation
Audit trail & CAPA system evaluation
Mock ANAMED‑style inspections & GMP audit preparation
Continuous compliance improvement for WHO GMP and global regulatory alignment
We assist sponsors, CROs, and pharmaceutical sites in Chile in enhancing quality systems, reducing compliance risks, and effectively managing inspections to ensure thorough preparedness before inspections occur.
Clinical & Scientific Expert Services in Chile for Drug Development
Empowering Pharmaceutical Innovation with Expert Services in Chile
To aid pharmaceutical and biotech companies in both early- and late-stage drug development, Zenovel offers clinical expert services in Chile. We improve drug development strategies, refine study designs, and accelerate regulatory readiness, ensuring compliance with ANAMED requirements, ICH E6(R3) guidelines, and international standards.
Our Clinical & Scientific Expert Services in Chile Include:
Clinical development strategy & protocol design
PK/PD interpretation & translational science support
Biomarker strategy, endpoint selection & study design optimization
Regulatory scientific consulting aligned with ANAMED and global guidelines
Zenovel collaborates with clinical, regulatory, and R&D teams to connect preclinical research with clinical execution, offering recommendations grounded in scientific reasoning and practical experience to enhance development efficiency and minimize uncertainty.
Medical & Scientific Writing Services in Chile for Regulatory Success
Supporting Chile’s Pharmaceutical and Healthcare Industry with Expert Medical Writing
Regulatory submissions in Chile require precise data and structured documentation to communicate effectively with ANAMED. Zenovel offers medical and scientific writing services to pharma, biotech, and CROs, transforming complex clinical data into compliant, submission‑ready documents, thus expediting the approval process.
Our Medical Writing Services in Chile Include:
Clinical study reports (CSR), protocols & investigator brochures (IB)
Informed consent forms (ICF) & CTD/eCTD modules
Pharmacovigilance documents & clinical summaries
Full alignment with ICH guidelines and ANAMED regulatory standards
Zenovel merges scientific expertise with regulatory accuracy to produce organized documents that facilitate swift reviews and approvals. Acting as an extension of regulatory and clinical teams, it alleviates documentation burdens and enhances submission quality, establishing itself as a reliable medical writing partner in Chile for timely, inspection‑ready regulatory reviews.
Preclinical Support Services in Chile for Early-Stage Drug Development
Advancing Innovative Therapies Through Preclinical Expertise in Chile
At Zenovel, we offer comprehensive preclinical support services to biotech and pharmaceutical companies in Chile, facilitating their transition from discovery to clinical readiness. The integration of scientific expertise with regulatory precision ensures reliable data packages, aiding in regulatory reviews and successful IND submissions to ANAMED, compliant with ICH E6(R3) and international standards.
Our Preclinical Support Services in Chile Include:
In vitro & in vivo studies, toxicology assessment & PK/PD analysis
Bioanalytical support & translational research
Lead compound optimization, risk identification & safety evaluation
Regulatory documentation aligned with ANAMED, ICH, and global standards
Zenovel’s integrated CRO preclinical support services in Chile optimize study design, minimize delays and costs, and improve data accuracy, facilitating quicker transitions to clinical phases while adhering to ICH and international standards for various therapies, thereby establishing itself as a trusted partner for clinical success in the region.
Regulatory Affairs & Compliance Services in Chile for Global Submissions
Offering End-to-End Regulatory Affairs Services in Chile for International Compliance
Zenovel’s Regulatory Affairs & Compliance Services in Chile support pharmaceutical and biotech companies in product development and market authorization, facilitating efficient submissions to the ANAMED, as well as international bodies like the FDA, EMA, and WHO.
Our Regulatory Affairs Services in Chile Include:
eCTD dossier preparation, IND/CTA submissions & NDA/BLA support
Labeling compliance, gap analysis, and regulatory intelligence
Lifecycle management & post‑approval maintenance
Alignment with ANAMED, ICH, WHO GMP, PIC/S, and global guidelines
We offer regulatory compliance services in Chile, helping sponsors minimize submission delays and risks. Our integrated approach promotes submission accuracy and supports swift global expansion, resulting in quicker and compliant product approvals.
Dossier Due Diligence Services for Regulatory Accuracy in Chile
Ensuring Regulatory Accuracy with Expert Dossier Due Diligence Services in Chile
A regulatory dossier may appear complete, but it can contain minor inconsistencies that delay review by ANAMED. Zenovel provides dossier due diligence services in Chile, ensuring compliance with national and global regulatory standards through thorough CTD/eCTD dossier reviews.
Our Dossier Due Diligence Services in Chile Include:
- Clinical data consistency & CMC documentation alignment
- Module integration & ICH guideline compliance
- Gap analysis for missing evidence, contradictions & formatting issues
- Submission risk assessment & quality assurance
- Alignment with ANAMED, PIC/S, and WHO requirements
Zenovel enhances submission strategies by collaborating with regulatory, clinical, and CMC teams to improve documentation clarity and coherence. This approach reduces submission risks, enhances quality assurance, and increases confidence during reviews by ANAMED and global health authorities, ensuring that submissions are fully validated before reaching Chilean regulators.
eCTD Compilation Services for Global Regulatory Submissions in Chile
We accelerate regulatory success in Chile with accurate and compliant eCTD services.
Update your regulatory approval process in Chile using expert eCTD compilation services for pharmaceutical, biotech, and life sciences companies. These services ensure accurate and compliant electronic submissions that adhere to ANAMED standards and international requirements, facilitating quicker market entry across Latin America and globally.
Our eCTD Compilation Services in Chile include:
Document formatting, module‑wise structuring & quality validation
Hyperlinking, publishing & submission readiness for ANAMED, PIC/S, and global authorities (FDA, EMA, WHO)
IND, NDA, ANDA, and BLA dossier management for global filings
Full compliance with evolving eCTD, ICH, and WHO GMP guidelines
Zenovel is focused on global regulatory submissions, emphasizing accuracy and efficiency to reduce errors and delays. This commitment improves data integrity and speeds up approval processes, positioning Zenovel as a trusted partner for electronic submissions in Chile.
Environmental Risk Assessment Services for Regulatory Compliance in Chile
We Ensure Environmental Compliance for Pharmaceutical Success in Chile
Pharmaceutical and biotech companies in Chile must utilize Environmental Risk Assessment Services to meet regulatory demands and support sustainable drug development. With oversight from ANAMED and alignment with WHO and ICH guidelines, early evaluation of active pharmaceutical ingredients (APIs) and formulations is essential for product approval and global submissions.
Phase I & Phase II environmental assessments
PEC/PNEC calculations & exposure modeling
Ecotoxicity evaluation & regulatory dossier preparation
Integration with global submission strategies (ANAMED, WHO, PIC/S)
Integrating environmental compliance early reduces approval risks and delays. Zenovel provides robust documentation for global submissions and lifecycle compliance—your trusted partner for environmental risk assessments in Chile.
EU QP Support Services for Batch Release Compliance in Chile
We Deliver Quality, Compliance, and Confidence in Every Batch
For Chilean pharmaceutical companies exporting to Europe, Qualified Person (QP) certification is mandatory for batch release within the EU, ensuring compliance with EU GMP Annex 16 standards. Zenovel offers expert EU QP support services to help Chilean manufacturers meet these requirements and access European markets.
Our EU QP Support Services for Chilean Exporters Include:
- Batch record review & GMP compliance verification
- Deviation assessment & quality documentation review
- Coordination with EU Qualified Persons for final certification
- Alignment with EU GMP Annex 16 and global regulatory expectations
- Support under ANAMED export guidelines and WHO GMP/PIC/S standards
Zenovel leverages batch release compliance expertise to minimize approval delays and risks, facilitating smooth product distribution across Europe. We are your trusted QP partner for compliant EU batch releases from Chile.
Regulatory Gap Analysis Services in Chile for Regulatory Compliance
Closing Compliance Gaps for Faster Regulatory Approvals
To accelerate submission success and identify compliance gaps early, Zenovel provides Regulatory Gap Analysis Services for pharmaceutical and biotech companies in Chile. We evaluate clinical, non‑clinical, and CMC documentation to ensure alignment with ANAMED requirements, ICH E6(R3), WHO GMP, PIC/S standards, and global benchmarks—essential for securing timely approvals in Chile and internationally.
Our Regulatory Gap Analysis Services in Chile Include:
- Dossier completeness & data integrity
- SOP compliance & submission readiness
- Gaps in IND, NDA, ANDA, and BLA applications (for global submissions)
- Actionable remediation plans for compliance optimization
- Alignment with ANAMED, PIC/S, ICH, and WHO requirements
Zenovel offers structured regulatory compliance services to reduce approval risks and improve submission quality. We identify deficiencies and provide practical solutions to enhance regulatory positioning, ensuring audit‑ready and globally compliant documentation.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
